DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Aldactone (Spironolactone) - Current Clinical Trials


Aldactone Related Clinical Trials

Interest of Topical Spironolactone's Administration to Prevent Corticoid-induced Epidermal Atrophy [Recruiting]

The Efficacy of Spironolactone in Patients With Resistant Hypertension [Not yet recruiting]

Hemodynamic Effects of Chronic Administration of Spironolactone and/or Propranolol in Alcoholic Cirrhotic Patients [Terminated]

Effect of Spironolactone and Vitamin E in Patients With Nonalcoholic Fatty Liver Disease [Recruiting]

Spironolactone Versus Amiloride as an Add on Agent in Resistant Hypertension [Not yet recruiting]

Spironolactone for Reducing Proteinuria in Diabetic Nephropathy [Completed]

Spironolactone in Patients With Single Ventricle Heart [Active, not recruiting]

Is Spironolactone Safe and Effective in the Treatment of Cardiovascular Disease in Mild Chronic Renal Failure? [Completed]

Clinical Trial Studying the Effects of Spironolactone on Heart and Skeletal Muscle Function in Chronic Alcoholics [Recruiting]

Spironolactone and Insulin Resistance in Chronic Heart Failure (CHF) [Completed]

Effects of Spironolactone on Matrix Metalloproteinases (MMPs) in Heart Failure [Completed]

Spironolactone and Prevention of Peritoneal Fibrosis in Peritoneal Dialysis [Recruiting]

Aliskiren and Renin Inhibition in Diastolic Heart Failure [Recruiting]

Spironolactone in Diabetic Nephropathy [Completed]

Using the Drug Spironolactone to Test If It Reduces Protein Leakage From the Kidney [Completed]

Spironolactone Combined With Captopril and Carvedilol for the Treatment of Pulmonary Arterial Hypertension [Completed]

RLY5016 in the Treatment of Hyperkalemia in Patients With Hypertension and Diabetic Nephropathy (AMETHYST-DN) [Recruiting]

The Effects of Amiloride and Spironolactone on Renophysiological and Cardiovascular Variables [Recruiting]

Clinical and Therapeutic Implications of Fibrosis in Hypertrophic Cardiomyopathy [Recruiting]

Aldosterone Blockade Early After Acute Myocardial Infarction [Recruiting]

Spironolactone Safety in Dialysis Patients [Recruiting]

Spironolactone to Decrease Potassium Wasting in Hypercalciurics on Thiazides Diuretics [Recruiting]

Larger Dose of Spironolactone for the Treatment of Patients With Nonischemic Cardiomyopathy [Recruiting]

Aldosterone and the Metabolic Syndrome [Recruiting]

Cardiovascular Protective Effect of Spironolactone in Hemodialysis [Recruiting]

The Combination Ambrisentan Plus Spironolactone in Pulmonary Arterial Hypertension Study [Not yet recruiting]

Effects of Spironolactone on Collagen Metabolism in Patients With Pulmonary Arterial Hypertension [Recruiting]

Acetazolamide and Spironolactone to Increase Natriuresis in Congestive Heart Failure [Recruiting]

Effect of Aldosterone on Energy Starvation in Heart Failure [Recruiting]

Autoregulation of Glomerular Filtration Rate in Patients With Type 1 Diabetes During Spironolactone Therapy [Completed]

Determining the Effect of Spironolactone on Electrolyte Supplementation in Preterm Infants With Chronic Lung Disease [Recruiting]

Spironolactone for Paroxysmal Atrial Fibrillation [Recruiting]

Treatment of Boys With Precocious Puberty [Completed]

L-Arginine and Spironolactone Trial in Dialysis-Dependent ESRD [Not yet recruiting]

Resistant Hypertension Optimal Treatment [Recruiting]

Effects of Spironolactone in Dialysis [Recruiting]

Study of High-dose Spironolactone vs. Placebo Therapy in Acute Heart Failure [Not yet recruiting]

The Effect of Spironolactone on Pain in Older People With Osteoarthritis [Recruiting]

Optimalization of Nephroprotection Using Agents Inhibiting Renin-Angiotensin-Aldosterone System [Completed]

Effect of Spironolactone on Adrenal or Ovarian Androgen Production in Overweight Pubertal Girls With Androgen Excess [Not yet recruiting]

Effect of Spironolactone in Treating Chronic Non-resolutive Central Serous Chorioretinitis [Recruiting]

Left Ventricular Hypertrophy and Spironolactone in End Stage Renal Disease [Completed]

Addition of Spironolactone in Patients With Resistant Arterial Hypertension [Recruiting]

Use of Spironolactone for the Prevention of Electrolyte Abnormalities in Patients Treated With Amphotericin B [Recruiting]

Comparison of Effects of Eplerenone Versus Spironolactone in Heart Failure Patients With Glucose Intolerance or Type 2 Diabetes [Recruiting]

Safety and Cardiovascular Efficacy of Spironolactone in Dialysis-Dependent ESRD Trial [Not yet recruiting]

Spironolactone in Adult Congenital Heart Disease [Recruiting]

A Study to Evaluate the Safety and Tolerability, How Body Handles the Compound (PF-03882845) and How Body Reacts to the Compound (PF-03882845) in Patients With Type 2 Diabetic Nephropathy. [Not yet recruiting]

SCREEN-HFI (SCReening Evaluation of the Evolution of New Heart Failure Intervention Study) [Recruiting]

Efficacy of Therapy With the Spironolactone Pills Compared to Minoxidil Lotion in Female Pattern Hair Loss [Recruiting]

Mineralocorticoid Receptor Antagonists in End Stage Renal Disease [Recruiting]

ALdosterone Antagonist Chronic HEModialysis Interventional Survival Trial [Recruiting]

PIE II: Pharmacological Intervention in the Elderly II [Active, not recruiting]

Mineralocorticoid Receptor and Obesity Induced Cardiovascular Complications [Recruiting]

Spironolactone for Pulmonary Arterial Hypertension [Recruiting]

The Effect of Amiloride and Spironolactone in Healthy Persons [Recruiting]

Phase II Study of the Effect of Leuprolide Acetate and Spironolactone on Insulin Resistance in Hyperandrogenic Women With Polycystic Ovarian Disease or Hyperandrogenism Insulin Resistance Acanthosis Nigricans Syndrome [Completed]

BAY94-8862 Dose Finding Trial in Subjects With Chronic Heart Failure and Mild (Part A) or Moderate (Part B) Chronic Kidney Disease [Recruiting]

Novel Treatment for Diastolic Heart Failure in Women [Recruiting]

Mineralocorticoid Receptor in the Treatment of Severe Depression [Completed]

Aldosterone in Diabetic Nephropathy [Recruiting]

Role of Mineralocorticoid Receptor in Diabetic Cardiovascular Disease [Recruiting]

Evaluation of RLY5016 in Heart Failure Patients [Recruiting]

Importance of Aldosterone in the Pathogenesis of Hypertensive Heart Disease [Recruiting]

Comparison of Two Treatments to Decrease Inflammation and Atrial Fibrillation Following Cardiopulmonary Bypass Surgery

Impact of Medical and Surgical Therapy on Functional Mitral Regurgitation [Completed]

Examining the Effect of Different Diuretics on Fluid Retention in Diabetics Treated With Rosiglitazone. [Completed]

Evaluation of Heart Failure Treatment Guided by NTproBNP vs Clinical Symptoms and Signs Alone [Recruiting]

Evaluating the Link Between Thiazide Medications, the Nervous System, and Diabetes in Individuals With High Blood Pressure [Recruiting]

Renin-Angiotensin-Aldosterone System (RAAS), Inflammation, and Post-Operative Atrial Fibrillation [Recruiting]

Aldosterone Blockade in Heart Failure [Recruiting]

Effect of Betablocker or Aldosterone Antagonist Therapy on Patients With Liver Cirrhosis [Recruiting]

Improving Outcomes in Patients With Kidney Disease Due to Diabetes [Completed]

Body Volume Regulation in Pulmonary Arterial Hypertenison With Right Ventricular Failure [Not yet recruiting]

Double Blind Crossover Comparison of Diuretics in the Young [Recruiting]

Renal Effects of Levosimendan in Patients Admitted With Acute Decompensated Heart Failure [Not yet recruiting]

STITCH2 (Simplified Therapeutic Intervention to Control Hypertension and Hypercholesterolemia) [Enrolling by invitation]

Renin-Guided Therapeutics in the Management of Untreated, Uncontrolled, or Complicated Hypertension [Completed]

The Effects of Clonidine on the Diuretic Response in Cirrhotic Patients [Completed]

Satavaptan Dose-Ranging Study in Normonatraemic Patients With Cirrhotic Ascites [Completed]

Liver Transplantation Versus Alternative Therapies for Patients With Pugh B Alcoholic Cirrhosis [Completed]

Satavaptan Dose-Ranging Study in the Prevention of Ascites [Completed]

Treatment of Preclinical Hypertrophic Cardiomyopathy With Diltiazem [Recruiting]

Satavaptan Dose-Ranging Study in Hyponatraemic Patients With Cirrhotic Ascites [Completed]

Antiremodeling Effect Of Aldosterone Receptors Blockade With Canrenone In Mild Chronic Heart Failure. AREA IN-CHF Study [Completed]

Management of Hyponatremia in Preterm Infants on Diuretics [Terminated]

Standard Drug Therapy vs. Implanted Defibrillator for Primary Prevention of Sudden Cardiac Death [Recruiting]

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2015